Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

UK drugmaker GSK is struggling to convince the market ... said investors were confident about the company’s ability to commercialise products, but saw its research and development as more ...

The study found that N6LS (VH3810109 or VH109), given every four months in combination with already marketed monthly ...

The deal includes two recently approved GSK products for metastatic melanoma ... lucrative and growing sectors in the industry. The UK-headquartered firm says this part of the deal represents ...